Common stock, par value $0.01 per share
- Symbol
- PBH
- Exchange
- NYSE
- Classification
- COMMON
- Status
- Current
Current Report · Items 9.01 · 8-K/A
Prestige Consumer Healthcare Inc.
PBHNYSEEQUITYCurrent
Financial Statements and Exhibits
Item 9.01 Exhibits. (a) Exhibits. Exhibit Description ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── 99.2 Unaudited Condensed Combined Financial Statements of the OTC Wellness Business (a portion of the operations of F…
Company context
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Breathe Right® nasal strips, Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Current securities
Recent company filings
Registered securities in this filing
PRESTIGE CONSUMER HEALTHCARE INC. · 8-K/A · Filed 2026-07-09
Disclosure sections
Item 9.01Item 9.01 - Financial Statements and Exhibits
Item 9.01 Exhibits.
(a) Exhibits.
Exhibit Description
────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
99.2 Unaudited Condensed Combined Financial Statements of the OTC Wellness Business (a portion of the operations of Foundation Consumer Brands, LLC) as of March 31, 2026 and for the three months ended March 31, 2026.